Nasdaq grants Avenue Therapeutics extension to Nov 15, 2023 for stockholders' equity compliance

AVENUE THERAPEUTICS, INC.

Nasdaq Staff granted extension until November 15, 2023 to regain compliance with minimum $2.5M stockholders' equity rule.
Company originally notified of deficiency on May 19, 2023 for not meeting Nasdaq Listing Rule 5550(b)(1).
Company intends to work diligently to regain compliance but cannot assure success.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.